For any questions or inquiries, please feel free to contact us.
ARENSIA begins Clinical Trial Program to test DIFFUSION’s lead drug for the treatment of hospitalized COVID-19 patients
We at ARENSIA are proud to announce today that we have entered into an agreement with Diffusion Pharmaceuticals Inc. (NA...
International Clinical Trials Day
On International Clinical Trials Day we congratulate all patients, all medical professionals and all employees involved ...
International Nurses Day
They are the heart of timely data collection with the efficiency of a Swiss Clock, no matter the complexity for sample c...
ARENSIA is committed to fight COVID-19!
We are eager to bring in all our expertise and clinical research infrastructure to contribute to Phase I, II and III cli...
ARENSIA delivers high degree of scientific and logistical expertise for Phase I/Ib/IIa and PROOF OF CONCEPT patient studies.
MORE
ARENSIA offers exceptional fast recruitment rates for renal and hepatic impaired patients.
MORE
ARENSIA has the know-how to successfully manage the regulatory process in various Eastern European countries.
MOREARENSIA Exploratory Medicine GmbH
Merowingerplatz 1
40225 Duesseldorf
Germany
Legal Representatives
Geschaeftsfuehrer / Managing Director: Dr. Claudia Hesselmann / Dr. Jochen Kraatz
Amtsgericht / Local Court: Düsseldorf, HRB 64937
Umsatzsteuer-Identifikationsnummer gemäß §27a Umsatzsteuergesetz: DE 27629 5755
VIDEO INTRO